flâneur

The PCOS opportunity: a deep dive into this unsolved area of women’s health

substack.com · 1,766 words · saved by 1 readers

No cure, a thin pharmaceutical pipeline and huge unmet need. Here are the innovators solving for this space.

Image: PCOS market map After more than a decade of campaigning work spearheaded by the UK charity Verity and Australia’s Monash University, Polycystic Ovary Syndrome is about to be renamed. It’s a big deal - for patients, providers and anyone who has worked in the space. Because for years, the name itself has shaped how PCOS is understood, diagnosed and treated - and arguably has contributed to the speed (or lack of) progress. Described by one patient as ‘misleading, medically outdated and emotionally invalidating’, ‘Polycystic Ovary Syndrome’ has never accurately represented PCOS as a…

related reading